MOELIS & COMPANY (MC) Financials

FY2025 annual

Revenue Not reported for FY2025

Net Income $233.0M +71.3% YoY

Free Cash Flow $540.0M +30.0% YoY

Operating Cash Flow $576.3M +34.8% YoY

Market Cap $4.0B as of Oct 23, 2026

Price / Sales n/m no revenue reported

Price / Earnings 17.3x on $233.0M net income, FY2025

Price / Book 8.0x on $505.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MC SEC filings page.

This page shows MOELIS & COMPANY (MC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MC FY2025 2026-10-22

Moelis’s FY2025 recovery converted profit into cash while receivables outpaced equity growth, showing greater working-capital exposure.

Cash conversion remained favorable, but FY2025 net income grew 71.4% while operating cash flow grew only 34.8%. Receivables grew 59.9%, even though operating cash flow still equaled 222.0% of net income, implying cash generation remained strong but lagged the earnings surge.

Earnings are cyclical: Moelis moved from a net loss of $28M in FY2023 to net income of $260M in FY2025. Return on equity likewise moved from -7.8% to 45.7%, reinforcing that reported performance can swing sharply across years.

The balance sheet became less liability-heavy: liabilities were 60.9% of assets in FY2025 versus 65.2% in FY2024. Liabilities-to-equity was 1.9x, while capital expenditures were only 6.3% of operating cash flow, so the model remains lightly capital-intensive.

Financial Health Signals

Financial health score not available

MOELIS & COMPANY does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

$77.0M

YoY+21.5%

QoQ+75.1%

MOELIS & COMPANY's EBITDA was $77.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 21.5% from the same quarter a year earlier. Against the prior quarter it is up 75.1%.

Net Income

$48.6M

YoY+17.0%

QoQ+26.4%

MOELIS & COMPANY reported $48.6M in net income in Q2 2026. This represents an increase of 17.0% from the same quarter a year earlier. Against the prior quarter it is up 26.4%.

Revenue

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$215.9M

YoY+8.2%

QoQn/m

5Y CAGR-2.8%

10Y CAGR+13.0%

MOELIS & COMPANY generated $215.9M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 8.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$207.7M

YoY-6.3%

QoQ+35.8%

5Y CAGR+1.1%

10Y CAGR+6.3%

MOELIS & COMPANY held $207.7M in cash as of Q2 2026; no long-term debt figure is on record for that period.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

Return on Equity

9.6%

YoY+1.6pp

QoQ+1.7pp

MOELIS & COMPANY's quarterly ROE was 9.6% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$13.7M

YoY+187.6%

QoQ+6.9%

5Y CAGR+15.8%

10Y CAGR+26.6%

MOELIS & COMPANY invested $13.7M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 187.6% from the same quarter a year earlier. Against the prior quarter it is up 6.9%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

MC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Income	N/A	$273.9M+58.4%	$172.9Mn/m	-$40.4M-118.7%	$216.1M-56.4%	$495.9M+86.6%	$265.7M+132.0%	$114.5M-49.5%	$226.8M+38.0%	$164.3M+2.0%	$161.1M+17.2%	$137.5M+188.0%	$47.7M-31.9%	$70.1M+84.3%	$38.0M
EBITDA	N/A	$285.7M+55.8%	$183.4Mn/m	-$32.0M-114.3%	$224.1M-55.5%	$503.2M+86.1%	$270.4M+126.3%	$119.5M-48.4%	$231.4M+37.9%	$167.8M+2.2%	$164.3M+17.2%	$140.1M+180.2%	$50.0M-30.9%	$72.4M+78.5%	$40.6M
Income Tax	N/A	$67.9M+52.4%	$44.5Mn/m	-$1.6M-103.4%	$47.6M-58.0%	$113.3M+119.3%	$51.7M+337.4%	$11.8M-61.2%	$30.4M-86.4%	$223.8M+802.2%	$24.8M+4.0%	$23.8M+73.6%	$13.7M+391.8%	$2.8M+11.8%	$2.5M
Net Income	N/A	$233.0M+71.3%	$136.0Mn/m	-$24.7M-116.4%	$150.3M-58.8%	$365.2M+104.2%	$178.8M+70.2%	$105.1M-25.3%	$140.7M+378.5%	$29.4M-23.4%	$38.4M+16.0%	$33.1Mn/m	-$3.0M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Income	$72.8M+20.1%	$40.5M+9.7%	N/A	$48.3M+210.4%	$60.6M+202.1%	$36.9M+536.2%	N/A	$15.6Mn/m
EBITDA	$77.0M+21.5%	$44.0M+10.8%	N/A	$51.3M+179.3%	$63.4M+181.7%	$39.7M+385.4%	N/A	$18.4Mn/m
Income Tax	$20.2M+15.9%	$3.9Mn/m	N/A	$22.2M+199.8%	$17.4M+153.6%	-$10.7Mn/m	N/A	$7.4M+476.9%
Net Income	$48.6M+17.0%	$38.4M-23.5%	N/A	$53.4M+215.9%	$41.5M+215.6%	$50.3M+203.4%	N/A	$16.9Mn/m

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

MC Balance Sheet

MC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$1.7B+26.2%	$1.4B+16.9%	$1.2B-3.0%	$1.2B-21.8%	$1.6B+30.0%	$1.2B+11.6%	$1.1B+17.2%	$914.4M+30.8%	$699.1M+16.7%	$598.8M+11.0%	$539.5M+16.2%	$464.2M+4.7%	$443.5M	N/A
Cash & Equivalents	$508.6M+23.3%	$412.5M+121.3%	$186.4M-9.9%	$206.8M-60.2%	$520.2M+156.9%	$202.5M+20.7%	$167.8M-35.7%	$261.1M+22.5%	$213.2M-33.2%	$318.9M+28.6%	$248.0M+25.3%	$197.9M-34.7%	$303.0M+63.2%	$185.6M
Short-Term Investments	N/A	N/A	N/A	$265.2M+0.7%	$263.3M+24.3%	$211.8M-0.7%	$213.2M+48.2%	$143.9M+49.8%	$96.1M	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$82.2M+59.9%	$51.4M+0.4%	$51.2M+7.1%	$47.8M+14.2%	$41.9M-53.1%	$89.3M+98.1%	$45.1M-17.2%	$54.4M-4.1%	$56.7M+144.9%	$23.2M-20.0%	$28.9M+25.9%	$23.0M-20.1%	$28.8M	N/A
Total Liabilities	$1.1B+17.9%	$899.6M+10.1%	$817.3M+7.8%	$757.9M-29.7%	$1.1B+43.3%	$752.0M+10.9%	$677.9M+24.9%	$542.6M+52.9%	$354.8M+2.1%	$347.4M+23.2%	$282.0M-2.7%	$289.9M+116.2%	$134.1M	N/A
Total Equity	$568.4M+28.7%	$441.6M+25.4%	$352.1M-20.8%	$444.5M-9.1%	$489.1M+1.9%	$479.9M+8.4%	$442.8M+9.5%	$404.4M+24.4%	$324.9M+53.4%	$211.8M+25.8%	$168.4M+48.5%	$113.4M-63.4%	$309.4M	N/A
Retained Earnings	-$801.2Mn/m	-$821.6Mn/m	-$767.6Mn/m	-$560.7Mn/m	-$535.3Mn/m	-$420.7Mn/m	-$324.2Mn/m	-$237.8Mn/m	-$139.9Mn/m	-$68.2Mn/m	-$15.3Mn/m	-$24.1M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.4B+4.9%	$1.3B+6.9%	$1.7B+26.2%	$1.5B+31.6%	$1.3B+27.8%	$1.2B+19.2%	$1.4B+16.9%	$1.2B+2.9%
Cash & Equivalents	$207.7M-6.3%	$152.9M-17.1%	$508.6M+23.3%	$281.6M+93.8%	$221.7M+47.4%	$184.5M+79.8%	$412.5M+121.3%	$145.3M-1.4%
Accounts Receivable	$66.9M+18.4%	$97.9M+76.6%	$82.2M+59.9%	$55.2M-4.4%	$56.5M+9.6%	$55.5M+11.0%	$51.4M+0.4%	$57.8M+126.4%
Total Liabilities	$766.6M+2.7%	$667.0M+4.1%	$1.1B+17.9%	$898.6M+18.6%	$746.5M+12.0%	$640.5M+3.3%	$899.6M+10.1%	$758.0M+2.4%
Total Equity	$505.8M-2.0%	$487.1M+0.5%	$568.4M+28.7%	$535.0M+45.6%	$516.0M+44.3%	$484.5M+32.9%	$441.6M+25.4%	$367.5M+0.1%
Retained Earnings	-$822.4Mn/m	-$817.3Mn/m	-$801.2Mn/m	-$836.7Mn/m	-$837.6Mn/m	-$825.1Mn/m	-$821.6Mn/m	-$862.1Mn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

MC Cash Flow Statement

MC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$488.3M	$576.3M+34.8%	$427.5M+169.8%	$158.5M+380.3%	$33.0M-96.5%	$937.0M+118.3%	$429.2M+105.1%	$209.3M-46.5%	$390.9M+67.6%	$233.2M+0.7%	$231.6M+62.2%	$142.8M-31.7%	$208.9M+77.6%	$117.7M+6.3%	$110.7M
Depreciation & Amortization	N/A	$11.9M+13.7%	$10.4M+25.6%	$8.3M+4.3%	$8.0M+10.1%	$7.2M+53.8%	$4.7M-5.2%	$5.0M+7.4%	$4.6M+30.5%	$3.5M+11.3%	$3.2M+20.8%	$2.6M+16.2%	$2.3M-1.2%	$2.3M-8.4%	$2.5M
Stock-Based Compensation	N/A	$230.3M+42.6%	$161.4M+2.1%	$158.2M+22.7%	$128.9M-23.2%	$167.9M+25.7%	$133.6M+7.6%	$124.2M+1.0%	$123.0M+27.8%	$96.3M+25.0%	$77.0M+67.0%	$46.1M-61.5%	$119.8M+142.6%	$49.4M+17.4%	$42.0M
Capital Expenditures	$54.9M	$36.3M+200.4%	$12.1M-27.6%	$16.7M+180.3%	$6.0M-63.7%	$16.4M-59.6%	$40.7M+528.7%	$6.5M-6.5%	$6.9M+22.5%	$5.6M+96.8%	$2.9M-28.2%	$4.0M+2.8%	$3.9M+139.6%	$1.6M-55.9%	$3.7M
Free Cash Flow	$433.4M	$540.0M+30.0%	$415.4M+193.0%	$141.8M+424.4%	$27.0M-97.1%	$920.6M+136.9%	$388.6M+91.6%	$202.8M-47.2%	$384.0M+68.8%	$227.5M-0.5%	$228.7M+64.8%	$138.8M-32.3%	$205.0M+76.7%	$116.0M+8.4%	$107.1M
Investing Cash Flow	-$47.4M	-$196.0M-1245.2%	$17.1M-64.8%	$48.6Mn/m	-$11.2Mn/m	-$17.0Mn/m	-$40.0Mn/m	-$51.9M-658.7%	$9.3Mn/m	-$69.4M-5120.5%	$1.4Mn/m	-$1.7M	N/A	N/A	N/A
Financing Cash Flow	-$451.8M	-$283.9Mn/m	-$215.1Mn/m	-$229.2Mn/m	-$326.9Mn/m	-$602.5Mn/m	-$351.8Mn/m	-$252.7Mn/m	-$351.7Mn/m	-$272.5Mn/m	-$158.0Mn/m	-$90.2M	N/A	N/A	N/A
Dividends Paid	N/A	N/A	$184.2M+1.1%	$182.2M+4.3%	$174.7M-63.6%	$480.0M+69.6%	$282.9M+35.3%	$209.2M-33.3%	$313.8M+22.7%	$255.7M+65.3%	$154.7M+91.2%	$80.9M-34.3%	$123.2M+207.1%	$40.1M	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$293K+27.9%	$229K-93.1%	$3.3M-56.5%	$7.6M	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$229.5M+12.4%	-$278.8Mn/m	$338.7M+7.4%	$198.9M+45.0%	$204.2M+45.9%	-$165.5Mn/m	$315.3M+217.4%	$137.2M-2.1%
Depreciation & Amortization	$4.2M+52.3%	$3.5M+25.7%	$3.4M+18.7%	$3.0M+6.2%	$2.8M+13.4%	$2.8M+17.0%	$2.8M+23.5%	$2.8M+39.1%
Stock-Based Compensation	$45.5M+9.3%	$72.2M-16.3%	N/A	$38.4M+6.2%	$41.6M+60.3%	$86.2M+43.8%	N/A	$36.2M+13.1%
Capital Expenditures	$13.7M+187.6%	$12.8M+312.0%	$9.2M+296.3%	$19.3M+829.9%	$4.8M+103.3%	$3.1M-42.2%	$2.3M-56.2%	$2.1M-56.1%
Free Cash Flow	$215.9M+8.2%	-$291.6Mn/m	$329.6M+5.3%	$179.6M+32.9%	$199.4M+44.9%	-$168.6Mn/m	$313.0M+232.8%	$135.1M-0.2%
Investing Cash Flow	-$92.1Mn/m	$127.6Mn/m	-$9.7M-363.8%	-$73.2Mn/m	-$106.1Mn/m	-$7.0M-105.4%	$3.7Mn/m	-$95.3Mn/m
Financing Cash Flow	-$81.3Mn/m	-$204.4Mn/m	-$99.5Mn/m	-$66.6Mn/m	-$61.1Mn/m	-$56.7Mn/m	-$47.0Mn/m	-$48.6Mn/m
Dividends Paid	N/A	N/A	N/A	N/A	$59.1M+14.9%	$45.1M+14.8%	$45.9M+2.7%	$47.6M+6.8%

Not reported in any period shown, so not listed: Share Buybacks.

MC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Return on Equity	41.0%+10.2pp	30.8%+37.8pp	-7.0%-40.8pp	33.8%-40.9pp	74.7%+37.4pp	37.3%+13.5pp	23.7%-11.1pp	34.8%+25.7pp	9.0%-9.1pp	18.1%-1.5pp	19.7%+22.3pp	-2.7%	N/A	N/A
Return on Assets	13.4%+3.5pp	9.9%+11.9pp	-2.1%-14.4pp	12.4%-11.1pp	23.5%+8.5pp	14.9%+5.1pp	9.8%-5.6pp	15.4%+11.2pp	4.2%-2.2pp	6.4%+0.3pp	6.1%+6.8pp	-0.7%	N/A	N/A
Liabilities-to-Equity	1.87-0.2x	2.04-0.3x	2.32+0.6x	1.71-0.5x	2.20+0.6x	1.570.0x	1.53+0.2x	1.34+0.3x	1.09-0.5x	1.640.0x	1.68-0.9x	2.56+2.1x	0.43	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Return on Equity	9.6%+1.6pp	7.9%-2.5pp	N/A	10.0%+5.4pp	8.1%+4.4pp	10.4%+5.8pp	N/A	4.6%+7.5pp
Return on Assets	3.5%+0.4pp	3.0%-1.2pp	N/A	3.5%+2.1pp	3.1%+1.8pp	4.2%+2.5pp	N/A	1.5%+2.4pp
Liabilities-to-Equity	1.52+0.1x	1.370.0x	1.87-0.2x	1.68-0.4x	1.45-0.4x	1.32-0.4x	2.04-0.3x	2.060.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Debt-to-Equity, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
MOELIS & COMPANY MC	FY2025	N/A	$233.0M	N/A	$4.0B	—
Lazard, Inc. LAZ	FY2025	$3.1B	$236.8M	7.6%	$3.6B	67/100
PJT Partners Inc. PJT	FY2025	$1.7B	$180.1M	10.5%	$6.0B	77/100
StoneX Group Inc. SNEX	FY2025	$131.0B	$305.9M	0.2%	$6.8B	64/100
Piper Sandler Companies PIPR	FY2025	$1.9B	$281.3M	14.8%	$4.6B	63/100
MARA Holdings, Inc. MARA	FY2025	$907.1M	-$1.3B	N/A	$2.7B	50/100

Where MOELIS & COMPANY Ranks

Frequently Asked Questions

Is MOELIS & COMPANY profitable?

Yes, MOELIS & COMPANY (MC) reported a net income of $233.0M in fiscal year 2025.

What is MOELIS & COMPANY's EBITDA?

MOELIS & COMPANY (MC) had EBITDA of $285.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is MOELIS & COMPANY's return on equity (ROE)?

MOELIS & COMPANY (MC) has a return on equity of 41.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is MOELIS & COMPANY's free cash flow?

MOELIS & COMPANY (MC) generated $540.0M in free cash flow during fiscal year 2025. This represents a 30.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MOELIS & COMPANY's operating cash flow?

MOELIS & COMPANY (MC) generated $576.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are MOELIS & COMPANY's total assets?

MOELIS & COMPANY (MC) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are MOELIS & COMPANY's capital expenditures?

MOELIS & COMPANY (MC) invested $36.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

What is MOELIS & COMPANY's liabilities-to-equity ratio?

MOELIS & COMPANY (MC) had a liabilities-to-equity ratio of 1.87 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

What is MOELIS & COMPANY's return on assets (ROA)?

MOELIS & COMPANY (MC) had a return on assets of 13.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is MOELIS & COMPANY's P/E ratio?

MOELIS & COMPANY (MC) trades at 17.3x earnings, its market capitalization divided by $233.0M net income, FY2025. The market capitalization is $4.0B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is MOELIS & COMPANY's price-to-sales ratio?

MOELIS & COMPANY (MC) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $4.0B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.